Editorial & Opinion
Allograft involvement with posttransplant lymphoproliferative disorders (PTLD) in recipients of liver transplant: a clinicopathological analysis of 17 cases.
العنوان: | Allograft involvement with posttransplant lymphoproliferative disorders (PTLD) in recipients of liver transplant: a clinicopathological analysis of 17 cases. |
---|---|
المؤلفون: | Cruz RJ Jr; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Surgery, UPMC, Pittsburgh, Pennsylvania, USA., Sasatomi E; Department of Pathology, University of North Carolina, Chapel Hill, North Carolina, USA., Hughes CB; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Surgery, UPMC, Pittsburgh, Pennsylvania, USA., Humar A; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Surgery, UPMC, Pittsburgh, Pennsylvania, USA., Minervini M; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Pathology, UPMC, Pittsburgh, Pennsylvania, USA. |
المصدر: | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Liver Transpl] 2024 Aug 01; Vol. 30 (8), pp. 862-865. Date of Electronic Publication: 2024 Apr 12. |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 100909185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-6473 (Electronic) Linking ISSN: 15276465 NLM ISO Abbreviation: Liver Transpl Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2023- : [Philadelphia] : Wolters Kluwer Health, Inc. Original Publication: Philadelphia, PA : W.B. Saunders Co., c2000- |
مواضيع طبية MeSH: | Liver Transplantation*/adverse effects , Lymphoproliferative Disorders*/etiology , Allografts*/pathology, Humans ; Male ; Female ; Middle Aged ; Adult ; Postoperative Complications/etiology ; Postoperative Complications/epidemiology ; Postoperative Complications/diagnosis ; Retrospective Studies ; Aged ; Treatment Outcome |
References: | Lauro A, Arpinati M, Pinna AD. Managing the challenge of PTLD in liver and bowel transplant recipients. Br J Haematol. 2015;169:157–72. Allen UD, Preiksaitis JK. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:e13652. Strouse PJ, Platt JF, Francis IR, Bree RL. Tumorous intrahepatic lymphoproliferative disorder in transplanted livers. AJR Am J Roentgenol. 1996;167:1159–62. Nuckols JD, Baron PW, Stenzel TT, Olatidoye BA, Tuttle-Newhall JE, Clavien PA, et al. The pathology of liver-localized post-transplant lymphoproliferative disease: A report of three cases and a review of the literature. Am J Surg Pathol. 2000;24:733–41. Elstrom RL, Andreadis C, Aqui NA, Ahya VN, Bloom RD, Brozena SC, et al. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant. 2006;6:569–76. |
تواريخ الأحداث: | Date Created: 20240412 Date Completed: 20240717 Latest Revision: 20240917 |
رمز التحديث: | 20240917 |
DOI: | 10.1097/LVT.0000000000000379 |
PMID: | 38607654 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1527-6473 |
---|---|
DOI: | 10.1097/LVT.0000000000000379 |